KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 60 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $71,279 | -4.8% | 79,058 | 0.0% | 0.00% | – |
Q4 2023 | $74,900 | -28.2% | 79,058 | -9.8% | 0.00% | – |
Q3 2023 | $104,313 | -53.2% | 87,658 | -3.7% | 0.00% | – |
Q2 2023 | $223,117 | +5.5% | 91,068 | +34.7% | 0.00% | – |
Q1 2023 | $211,550 | -55.5% | 67,588 | 0.0% | 0.00% | – |
Q4 2022 | $475,820 | -9.0% | 67,588 | +11.4% | 0.00% | – |
Q3 2022 | $523,000 | +4.2% | 60,688 | 0.0% | 0.00% | – |
Q2 2022 | $502,000 | -90.2% | 60,688 | -80.4% | 0.00% | -100.0% |
Q1 2022 | $5,142,000 | +351.1% | 309,386 | +353.6% | 0.00% | – |
Q4 2021 | $1,140,000 | +69.9% | 68,200 | -12.2% | 0.00% | – |
Q3 2021 | $671,000 | +59.0% | 77,700 | 0.0% | 0.00% | – |
Q2 2021 | $422,000 | -7.0% | 77,700 | +2.0% | 0.00% | – |
Q1 2021 | $454,000 | +11.5% | 76,200 | -2.2% | 0.00% | – |
Q4 2020 | $407,000 | +8.0% | 77,900 | 0.0% | 0.00% | – |
Q3 2020 | $377,000 | -6.7% | 77,900 | 0.0% | 0.00% | – |
Q2 2020 | $404,000 | +438.7% | 77,900 | +355.6% | 0.00% | – |
Q1 2020 | $75,000 | +74.4% | 17,100 | +59.8% | 0.00% | – |
Q4 2019 | $43,000 | +22.9% | 10,700 | 0.0% | 0.00% | – |
Q3 2019 | $35,000 | -57.3% | 10,700 | 0.0% | 0.00% | – |
Q2 2019 | $82,000 | – | 10,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |